Señales en vivo de ETTX | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (4 jun 2024 @ 16:00):

Stats
Volumen de hoy	68 834
Volumen promedio	0
Capitalización de mercado	0.00
EPS	$-0.320 ( Q1 \| 2022-04-27 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.950 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0320 (1.46%)

AADI -8.24%

ABCL 1.28%

ABCM 0.04%

ABEO -3.32%

ABIO -1.68%

ABOS 3.98%

ABSI 3.74%

ABUS -0.82%

ABVX -3.00%

ACAD -0.45%

ACER -17.95%

ACET -9.15%

ACGN 1.29%

ACHL -2.48%

ACHV 3.66%

ACIU -1.50%

ACLX -0.44%

ACRV -5.28%

ACST -1.63%

ACXP 3.92%

ADAG 6.07%

ADAP -3.42%

ADGI 0.87%

ADIL -1.75%

ADMA -1.95%

ADPT 1.02%

ADTX -2.78%

ADVM 1.01%

ADXN -1.60%

AEON -2.80%

AEZS -2.49%

AFMD -2.97%

AGEN -4.17%

AGIO -2.09%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 4.30%

AKRO -2.55%

AKTX 0.35%

AKUS 0.00%

ALBO 0.00%

ALDX -2.10%

ALEC -0.11%

ALGS -1.52%

ALKS 1.61%

ALLK -11.39%

ALLO -4.17%

ALLR -1.47%

ALNA 3.16%

ALNY 2.02%

ALPN 0.02%

ALPX 0.00%

ALRN -1.67%

ALT -14.17%

ALVR -0.76%

ALXN 0.00%

ALXO -14.22%

ALZN 4.02%

AMRN -2.48%

AMTI -3.13%

ANAB 1.01%

ANEB 6.06%

ANGN 0.00%

ANIX -3.04%

ANL -0.14%

ANNX 2.07%

ANPC -3.15%

APGE 1.01%

APGN 8.48%

APGNW 30.65%

APLM -5.90%

APLS 0.79%

APLT -1.35%

APM 1.26%

APOP 0.38%

APRE 0.84%

APTO 0.62%

APTX 3.17%

APVO 0.93%

ARAV -13.39%

ARCT -6.47%

ARDS -12.13%

ARDX 0.50%

ARGX -0.59%

ARNA 0.00%

ARPO -0.90%

ARQT -2.97%

ARTL -2.50%

ARTLW 0.00%

ARVN 7.79%

ARWR -1.86%

ASLN -3.44%

ASMB -4.22%

ASND -2.18%

ATAI -5.17%

ATHA 6.89%

ATHE 0.56%

ATHX -33.50%

ATNF 0.99%

ATOS 5.85%

ATRA -3.60%

ATXI -2.78%

ATXS -0.94%

AUPH -1.17%

AURA 4.26%

AUTL -3.74%

AVBP -5.03%

AVEO 0.00%

AVIR -2.19%

AVRO -1.41%

AVTE -1.03%

AVTX -3.74%

AVXL -5.43%

AXLA 0.00%

AXSM -1.39%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.54%

BCAB -5.56%

BCDA -3.75%

BCDAW -41.77%

BCEL 0.00%

BCLI 5.82%

BCRX 1.80%

BCTX 10.20%

BCTXW 13.02%

BCYC 1.00%

BDRX -4.01%

BDTX -0.64%

BEAM 2.19%

BFRA -2.91%

BGNE -2.25%

BIOR -4.69%

BIVI 2.79%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -3.18%

BLTE -1.13%

BLU 0.03%

BLUE -2.28%

BMEA -14.20%

BMRN 0.51%

BNOX 6.15%

BNTC -3.06%

BNTX -1.77%

BOLD -9.03%

BOLT -0.05%

BPMC -1.64%

BPTH -1.43%

BPTS -13.47%

BRNS -0.37%

BRTX -4.29%

BTAI 12.29%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.36%

CABA 1.66%

CADL 0.53%

CALA 0.00%

CALC -9.65%

CALT -1.59%

CAPR -0.43%

CARA -3.23%

CARM 7.39%

CASI 3.86%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 0.56%

CCCC -2.76%

CCXI 0.00%

CDAK 0.00%

CDIO -2.99%

CDIOW 24.00%

CDMO -1.41%

CDMOP 0.04%

CDT -1.68%

CDTTW -39.60%

CDTX -6.44%

CDXC 7.58%

CDXS 8.25%

CELC -3.49%

CELU 1.33%

CELUW 11.80%

CERC -1.68%

CERE -1.62%

CERO -6.70%

CEROW -10.18%

CFRX -27.95%

CGEM -0.24%

CGEN -3.31%

CGON -1.45%

CGTX -4.35%

CHMA -6.00%

CHRS 3.81%

CINC 0.00%

CING 2.22%

CINGW 34.95%

CKPT -1.91%

CLBS -16.75%

CLDX -1.19%

CLGN 0.00%

CLLS -3.13%

CLNN -2.72%

CLNNW 0.00%

CLRB 7.04%

CLSD -2.40%

CLSN -0.68%

CLVS 0.00%

CMMB -3.89%

CMND 4.84%

CMPI 0.00%

CMPX 0.00%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.38%

CNCE 0.00%

CNSP -35.21%

CNST 0.00%

CNTA 0.67%

CNTB -0.75%

CNTX -7.31%

COCP -2.00%

COEPW 32.45%

COGT -2.28%

CORT 2.34%

COYA -0.33%

CPRX -1.91%

CRBP -0.74%

CRBU -7.10%

CRDF 0.66%

CRGX -0.74%

CRIS -1.59%

CRNX -6.37%

CRSP 0.02%

CRTX 2.63%

CRVO -3.95%

CRVS 0.56%

CSBR -0.19%

CTCX -1.59%

CTIC 0.06%

CTMX -3.31%

CTNM 1.98%

CTXR -1.34%

CUE -3.11%

CVAC -7.20%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 8.49%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -2.94%

CYTO 0.00%

DARE 2.94%

DAWN -0.90%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 29.20%

DNLI -2.23%

DNTH -6.46%

DOMH 1.59%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 0.46%

DRTSW 0.00%

DRUG 1.43%

DSGN -2.72%

DTIL 0.63%

DYAI 9.68%

EARS -1.77%

EDIT -3.02%

EDSA 4.09%

EFTR 2.50%

EFTRW -51.85%

EIGR -9.21%

ELAB -3.01%

ELDN 8.40%

ELEV -2.07%

ELOX 10.77%

ELTX -5.15%

ELVN -1.40%

ELYM 5.09%

ENGN 0.86%

ENGNW 0.00%

ENLV 0.00%

ENOB 1.79%

ENSC 6.53%

ENTA -0.73%

ENTO -4.97%

ENTX -1.34%

ENVB 4.72%

EPIX -0.72%

EPRX -1.92%

EPZM 0.00%

EQ -0.90%

EQRX -2.09%

EQRXW 0.00%

ERAS 1.68%

ERNA -2.78%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -4.58%

ETON 2.90%

ETTX 0.00%

EVAX -0.71%

EVGN 5.02%

EVLO 0.00%

EWTX -0.81%

EXAI -0.94%

EXEL 0.52%

EYEG -0.69%

EYEN 0.00%

EYPT 0.97%

FATE -11.96%

FBIO 0.59%

FBIOP 0.87%

FBLG -4.80%

FBRX -0.02%

FDMT -5.68%

FENC -2.52%

FGEN -9.87%

FHTX 6.96%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.57%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 1.38%

FULC 1.00%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -0.45%

GANX -3.08%

GBIO -2.33%

GBT 0.01%

GDTC 0.50%

GERN -2.44%

GHRS -3.72%

GLMD -4.09%

GLPG -1.71%

GLSI 5.01%

GLTO -3.31%

GLUE -3.69%

GLYC -12.38%

GMAB -0.47%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.34%

GNLX -4.65%

GNPX -3.43%

GNTA 3.94%

GOSS -9.45%

GOVX -1.36%

GOVXW 10.89%

GPCR -7.02%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.44%

GRTX -1.66%

GTHX 1.82%

GUTS 0.34%

GXGXW 41.67%

GYRE -4.99%

HALO -1.62%

HARP 0.09%

HCWB -6.13%

HEPA -3.50%

HGEN -84.62%

HILS 5.66%

HLVX -1.30%

HOOK 1.97%

HOTH -1.64%

HOWL 0.85%

HRMY 3.59%

HRTX 8.36%

HSTO 0.00%

HUMA 1.12%

HUMAW -6.26%

IBRX -6.32%

ICCC -3.10%

ICPT 0.21%

ICU 16.82%

ICUCW 9.30%

ICVX -0.91%

IDRA -23.04%

IDYA -3.29%

IFRX -2.78%

IGMS -1.39%

IKNA -0.89%

IKT -9.93%

IMAB 0.00%

IMCR -3.41%

IMGN 0.02%

IMGO 0.00%

IMMP 5.13%

IMMX -6.90%

IMNM 3.73%

IMNN 0.89%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -3.15%

IMTX -1.38%

IMTXW 6.00%

IMUX 2.31%

IMV 0.00%

IMVT -3.52%

INAB -0.72%

INBX -2.65%

INCY -2.25%

INDP 7.34%

INFI -52.38%

INKT 1.69%

INM 0.04%

INMB 4.65%

INO 2.86%

INSM -1.03%

INTS -1.96%

INVA 0.28%

INZY 1.72%

IOBT -10.24%

IONS 1.17%

IOVA -2.72%

IPA 3.00%

IPHA 5.08%

IPSC -2.73%

IRON -2.67%

ISEE 0.38%

ITOS 1.57%

ITRM 2.33%

IVA 6.96%

IVVD -0.41%

JAGX 1.05%

JANX -4.70%

JAZZ -1.01%

JNCE 0.00%

JSPR -2.25%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -2.45%

KALV -3.16%

KDNY 0.22%

KMPH -0.34%

KNSA -2.03%

KNTE -0.38%

KOD -7.71%

KPRX -4.08%

KPTI -8.49%

KRBP -10.00%

KRON 1.58%

KROS -0.53%

KRRO -2.42%

KRTX 0.03%

KRYS 0.19%

KTRA 14.31%

KTTA -0.65%

KTTAW 0.92%

KURA 0.68%

KYMR -3.37%

KYTX -4.13%

KZIA 2.40%

KZR -0.21%

LABP 0.57%

LBPH -0.32%

LBPS 0.00%

LBPSW 14.81%

LEGN 0.79%

LENZ -2.77%

LEXX -1.54%

LEXXW -14.63%

LGND -1.18%

LGNDV 0.00%

LGVN -10.14%

LIAN -8.28%

LIFE 2.70%

LIPO -5.28%

LIXT -9.76%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 0.70%

LPCN -3.68%

LPTX -2.75%

LQDA -0.16%

LRMR -0.07%

LSTA -1.68%

LTRN 5.74%

LUMO 1.79%

LVTX -4.12%

LXEO -8.68%

LXRX -1.76%

LYEL -35.05%

LYRA 3.99%

MACK 0.10%

MBIO -11.22%

MBRX -1.43%

MCRB 2.61%

MDGL -2.24%

MDNA -13.16%

MDWD 3.56%

MDXG -2.14%

MEIP 0.00%

MESO -1.71%

MGNX -5.36%

MGTA -7.74%

MGTX -0.71%

MGX 2.14%

MIRM 0.36%

MIRO 0.59%

MIST 3.08%

MITO 0.00%

MLEC -5.95%

MLECW 2.31%

MLND -5.36%

MLTX -0.03%

MLYS -6.49%

MNKD -0.76%

MNMD 2.97%

MNOV -1.06%

MNPR -8.54%

MOLN 2.20%

MOR 0.42%

MORF -3.15%

MREO 0.29%

MRKR -0.43%

MRNA -9.10%

MRNS -6.25%

MRSN -2.86%

MRTX -0.17%

MRUS -0.26%

MRVI 0.07%

MTCR -1.29%

MTEM 6.93%

MTP -18.50%

MURA -4.02%

MYMD 1.08%

NAMS 0.00%

NAMSW -0.21%

NAUT 0.89%

NBRV 0.71%

NBSE -1.56%

NBTX 8.40%

NCNA 0.37%

NERV -1.58%

NEXI -0.74%

NGM -1.28%

NGNE 3.31%

NKGN 9.85%

NKGNW -18.03%

NKTR 3.27%

NKTX -3.43%

NLSP 3.53%

NLSPW 26.67%

NMRA -2.00%

NMTR -42.97%

NOVN -24.84%

NRBO 14.44%

NRIX -0.79%

NRSN -4.82%

NRSNW 0.00%

NRXP -7.46%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.62%

NTEC -12.45%

NTHI 0.00%

NTLA -5.54%

NTRBW -31.07%

NUVL -1.27%

NVAX -7.10%

NVCT -7.46%

NVIV -34.28%

NXTC -5.29%

NYMX -0.05%

OABI 2.64%

OABIW -10.06%

OBIO 1.90%

OBSV 0.00%

OCEA -2.82%

OCGN 8.47%

OCS -1.00%

OCUL 0.61%

OCUP 1.31%

ODT -4.27%

OKYO 1.72%

OLMA -5.37%

OMER -2.57%

OMGA -0.42%

ONCO 5.89%

ONCR -3.08%

ONCS 31.87%

ONCT -2.35%

ONCY 2.97%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT -4.00%

ORGS -0.69%

ORIC -3.56%

ORMP 18.08%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.25%

OVID 0.30%

OYST 0.00%

PALI -0.22%

PASG 0.00%

PBLA -7.50%

PBM -4.69%

PBYI 2.87%

PCSA -1.93%

PCVX -0.09%

PDSB -6.81%

PEPG 1.37%

PGEN -7.19%

PHAR 2.19%

PHAS 0.00%

PHAT -0.92%

PHIO -3.55%

PHIOW 36.47%

PHVS -5.83%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -2.38%

PLUR 7.39%

PMN -5.55%

PMVP -2.98%

PNT 0.16%

PPBT -6.87%

PRAX 6.98%

PRDS 0.93%

PRLD -3.43%

PROG -3.47%

PROK -0.67%

PRQR 1.21%

PRTA -2.99%

PRTC 0.62%

PRTG 0.54%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -12.97%

PSTX -2.91%

PTCT -0.54%

PTE -0.82%

PTGX -1.02%

PTIXW -48.41%

PULM 1.56%

PXMD 4.76%

PYPD 1.71%

PYXS 3.76%

QLGN -2.78%

QNCX 5.70%

QNRX -0.08%

QSI -31.15%

QSIAW -3.13%

QTTB 1.83%

QURE -1.08%

RAIN -1.63%

RANI 4.81%

RAPT -2.27%

RARE 2.11%

RCKT -10.02%

REGN -0.39%

RENB -3.73%

REPL -2.27%

RETA 0.02%

REUN -0.89%

REVB -1.86%

REVBU 3.46%

REVBW 5.00%

RGLS -6.06%

RGNX -6.66%

RIGL -6.25%

RLAY -4.90%

RLMD 0.00%

RLYB -4.36%

RNA 1.84%

RNAC -4.53%

RNAZ -0.96%

RNXT 1.79%

ROIV -1.94%

ROIVW 4.56%

RPHM -1.86%

RPRX -0.74%

RPTX -0.88%

RUBY 2.70%

RVLP -32.05%

RVMD -0.86%

RVMDW -29.90%

RVNC -0.21%

RVPH -0.79%

RVPHW -5.28%

RXDX 0.09%

RXRX -6.35%

RYTM -6.28%

RYZB 0.02%

RZLT 2.07%

SABS -1.37%

SABSW -11.81%

SAGE 0.00%

SANA -2.86%

SAVA -2.10%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 2.59%

SCPH 9.85%

SCPS 0.00%

SEEL -4.87%

SEER 0.30%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.39%

SGMT -5.55%

SGTX -2.56%

SIOX 22.63%

SLDB -2.76%

SLGL 5.23%

SLN -7.52%

SLNO 0.62%

SLRX -0.81%

SLS -2.56%

SMMT -3.37%

SNDX 2.97%

SNGX 2.08%

SNPX 0.23%

SONN -2.15%

SPPI -0.49%

SPRB -1.36%

SPRC -4.25%

SPRO 0.75%

SRNE 0.00%

SRPT -1.21%

SRRA 0.00%

SRRK -1.98%

SRZN -2.45%

STAB 0.00%

STOK -7.20%

STRO -2.51%

STSA 0.00%

STTK 6.47%

SURF -0.93%

SVRA -2.76%

SWTX -0.44%

SYBX 1.29%

SYRS -2.24%

TALS -0.73%

TARA -7.38%

TARS -2.13%

TBPH 0.71%

TCBP 9.58%

TCDA 0.00%

TCON 0.00%

TCRR 0.00%

TCRT -1.75%

TCRX 3.39%

TECH -0.83%

TENX -0.32%

TERN -8.34%

TFFP -7.61%

TGTX -7.48%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -6.26%

TNGX -3.35%

TNXP -6.40%

TNYA -4.38%

TPST 5.38%

TRDA -4.77%

TRVI 2.68%

TRVN 0.68%

TSHA -18.86%

TSVT -4.12%

TTNP -6.05%

TVTX 3.20%

TYRA -6.83%

UBX -2.13%

UNCY -4.00%

URGN 2.49%

UTHR -0.11%

VACC 11.36%

VALN -6.70%

VAXX 106.25%

VBIV 0.91%

VBLT -8.77%

VCEL 0.98%

VCNX 8.60%

VCYT -1.01%

VERA -5.26%

VERU 2.69%

VERV -2.87%

VIGL -1.08%

VINC 2.93%

VIR -1.08%

VIRI -5.66%

VIRX 3.98%

VKTX -1.67%

VLON -13.04%

VNDA -3.99%

VOR -6.05%

VRCA 0.50%

VRDN -4.15%

VRNA -1.93%

VRPX 1.02%

VRTX 0.08%

VSTM 4.12%

VTGN -1.20%

VTVT 0.39%

VTYX -3.14%

VXRT -1.86%

VYGR -0.83%

VYNE -6.29%

VYNT 7.78%

WINT -2.72%

WVE -9.23%

XBIO 1.03%

XBIT 6.72%

XCUR 3.13%

XENE -1.77%

XERS 4.52%

XFOR 4.69%

XLO 4.42%

XLRN 0.00%

XNCR 0.26%

XOMA -8.79%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.55%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.73%

ZNTL -1.79%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2022-07-08	Innoviva Strategic Opportunities Llc	Buy	7 598 814	Common Stock
2022-07-07	Tommasi Ruben	Sell	39 596	Common Stock
2022-07-11	Tommasi Ruben	Sell	150 000	Common Stock
2022-07-11	Tommasi Ruben	Sell	98 700	Stock Option (right to buy)
2022-07-11	Tommasi Ruben	Sell	50 000	Stock Option (right to buy)

INSIDER POWER
52.71
Last 98 transactions
Buy: 9 607 238 \| Sell: 3 128 729

Volumen Correlación

Largo: 0.20 (neutral)

Corto: -0.50 (neutral)

Signal:(62.724) Neutral

Entasis Therapeutics Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Entasis Therapeutics Correlación - Moneda/Commodity

0.33
( neutral )

-0.29
( neutral )

0.00
( neutral )

0.38
( neutral )

0.00
( neutral )

-0.69
( moderate negative )

Entasis Therapeutics Finanzas

Annual	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-0.996

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-0.996

FY	2020
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-2.10

FY	2019
Ingresos:	$7.00M
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-3.33

Financial Reports:

No articles found.

Entasis Therapeutics Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Entasis Therapeutics

Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibacterial products to treat serious infections caused by multidrug-resistant pathogens in the United States. Its lead product candidate is sulbactam-durlobactam (SUL-DUR), a novel IV antibiotic that is in Phase III clinical trial for the treatment of pneumonia and bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii. The company also develops Zoliflodacin, a novel orally administered molecule, which is in Phase III clinical trial for the treatment of uncomplicated gonorrhea; ETX0282CPDP, an oral drug that is in Phase I clinical trial for the treatment of urinary tract infections; and ETX0462, a drug candidate from NBP platform that is in pre-clinical stage for the treatment of multidrug-resistant gram-negative infections. The company has a license and collaboration agreement with Zai Lab (Shanghai) Co., Ltd. for the development of durlobactam and SUL-DUR; and collaboration agreement with Global Antibiotic Research and Development Partnership for the development and commercialization of a product candidate zoliflodacin. Entasis Therapeutics Holdings Inc. was founded in 2015 and is headquartered in Waltham, Massachusetts. Entasis Therapeutics Holdings Inc. operates as a subsidiary of Innoviva, Inc.